Advisor Partners II’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.66M Buy
50,304
+2,342
+5% +$123K 0.11% 202
2023
Q2
$2.59M Buy
47,962
+3,092
+7% +$161K 0.12% 162
2023
Q1
$2.24M Buy
44,870
+1,484
+3% +$69.9K 0.12% 166
2022
Q4
$2.01M Buy
43,386
+4,855
+13% +$210K 0.12% 182
2022
Q3
$1.49M Buy
+38,531
New +$1.55M 0.11% 192

Other funds holding BSX

Advisor Partners II's BSX Position: Q3 2023 in Review

Advisor Partners II increased its Boston Scientific (BSX) stake by 4.9% in Q3 2023, buying an estimated $123K and bringing the position to 50,304 shares worth $2.66M. The position accounts for 0.11% of the portfolio, ranked #202.

Advisor Partners II first reported a position in BSX in Q3 2022 and has held it in 5 quarters since. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Advisor Partners II held 50,304 shares of Boston Scientific worth $2.66M as of Q3 2023.
  • Advisor Partners II bought 2,342 Boston Scientific shares in Q3 2023, an estimated $123K.
  • Boston Scientific made up 0.11% of Advisor Partners II's portfolio in Q3 2023, its #202 holding.
  • Advisor Partners II first reported a position in Boston Scientific in Q3 2022 and has held it in 5 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.